CTA-PB

E. I. du Pont de Nemours and Company (DuPont) - 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2004. DuPont is a diversified science and technology company operating globally. The reporting period is significantly impacted by the strategic divestiture of the Textiles & Interiors segment (INVISTA) to Koch Industries, completed on April 30, 2004, and the consolidation of the DuPont Dow Elastomers LLC (DDE) joint venture as a Variable Interest Entity (VIE) in April 2004.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Q2 2004 net sales increased 2% year-over-year, driven by 6% higher volumes and 4% higher prices, partially offset by the loss of INVISTA sales. YTD sales increased 9%.
• Profitability: Net income decreased 25% in Q2 and 3% YTD compared to 2003. The decline is primarily due to significant one-time charges totaling $302 million (after-tax) in Q2 and $598 million (after-tax) YTD.
• Major Charges:
  • INVISTA Divestiture: $183 million charge in Q2 (including $118 million loss on sale) and $345 million in Q1.
  • Restructuring: $433 million in employee separation and asset impairment charges in Q2, related to cost reduction initiatives following the INVISTA sale.
  • Legal/Litigation: $150 million reserve for DDE antitrust litigation (Q1) and $45 million reserve for PFOA class action (Q2).
• Liquidity: Net debt decreased significantly from $7.1 billion to $4.0 billion, largely due to $3.77 billion in net proceeds from the sale of INVISTA.

Guidance, Outlook, and Risks

• Outlook: Management expects R&D spending to total approximately $1.2 billion for the full year. Capital spending is expected to be about $1.4 billion. The company anticipates that cash from operations and debt capacity will be adequate to meet future requirements.
• Cost Savings: Recent workforce reductions (approx. 2,700 employees) are expected to deliver $225 million in annualized savings, with roughly 40% benefiting 2004 results.
• Key Risks and Contingencies:
  • Antitrust Litigation (DDE): Ongoing investigations in the U.S., EU, and Canada regarding synthetic rubber markets. DuPont has agreed to bear liabilities up to $150 million, with potential for higher costs.
  • Environmental (PFOA): EPA investigations and class action lawsuits regarding perfluorooctanoic acid. A $45 million reserve has been established, but a range of potential losses cannot be estimated.
  • Benlate Litigation: Ongoing product liability claims regarding crop damage and shrimp farming. Costs incurred to date are approximately $1.9 billion, with $250 million recovered via insurance.
  • Raw Material Costs: Performance Materials segment is sensitive to oil and natural gas prices; the company may not fully offset cost increases.

Investor Verification Checklist

• INVISTA Sale Finalization: Verify the final purchase price adjustment regarding net working capital and the transfer of equity affiliate interests, which could impact final proceeds by up to $168 million.
• Restructuring Execution: Monitor the timeline for the completion of employee terminations (expected by June 2005) and the realization of the projected $225 million in annualized savings.
• Litigation Reserves: Track developments in the DDE antitrust investigations and PFOA class action lawsuits, as actual losses could exceed current accruals ($150M and $45M respectively).
• Debt Maturities: Review the impact of the new $1.4 billion debt offering (notes due 2010 and 2014) on future interest obligations and liquidity.
• Segment Performance: Assess the standalone performance of remaining segments (e.g., Agriculture & Nutrition, Pharmaceuticals) excluding the volatility of the divested Textiles & Interiors segment.